Writing
Longer pieces on compounds people actually compare, written to the same rule as the rest of this site: what the literature reports, what is unknown, and no dose for you. If a question needs a number we cannot source, the piece says so instead of inventing one.
Compounds compared · 7 min
Retatrutide adds a glucagon receptor to tirzepatide's two. What the published trials report, why no equivalent dose exists, and what to track through a switch.
Read →Compounds compared · 6 min
Two receptors versus three. What SURMOUNT and the phase 2 retatrutide data each reported, on what populations, and what that does and does not let you conclude.
Read →Tracking · 5 min
A switch is the one time your own record beats anybody's protocol. What is worth writing down, and why a gap in the data is itself a finding.
Read →Every figure here is sourced the way the editorial policy describes. Nothing on this site prescribes, diagnoses or recommends.